Hutchison China Meditech Share Chat (HCM)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Hutchison China Meditech	LSE:HCM	London	Ordinary Share	KYG4672N1016	ORD USD1

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+220.00p	+4.36%	5,270.00p	5,240.00p	5,300.00p	5,270.00p	5,110.00p	5,130.00p	92,906	16:12:09

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	178.6	-39.6	-31.8	-	3,506.27

Hutchison China Meditech Share Discussion Threads

Showing 1801 to 1825 of 1825 messages

Chat Pages: 73 72 71 70 69 68 67 66 65 64 63 62 Older

Date	Subject	Author	Discuss
13/12/2018 14:13	agreed Lauders, there was also a dosing issue recently with 523 but that was not reported presumably because it's midway through. We certainly need progress now as approval of the Fruquintinib NDA in September resulted in no reaction from the market.	nerdofsteel	Read Full Thread Reply
13/12/2018 12:38	Just hoping one or both are not as disappointing as the FALUCA results NofS. That would be a big disappointment and we would no doubt be knocked back quite a bit.	lauders	Read Full Thread Reply
13/12/2018 11:38	The big one is Savolitinib, especially these......... Initiate global study of savolitinib/ Tagrisso® combo in 2L/3L NSCLC post Tagrisso® failure; AZ presents data on c-Met resistance; regulatory dialogue; Molecular epidemiology study (n>200) in PRCC [3] – possibly BTD enabling. We can expect news on both of these studies in the next 2 weeks ;o-)	nerdofsteel	Read Full Thread Reply
13/12/2018 08:12	Still at a £1+ discount to the US share price.	nhb001	Read Full Thread Reply
13/12/2018 07:21	chartwise, looks like this is making a nice bowl	mad foetus	Read Full Thread Reply
13/12/2018 01:56	Hoping for a great day here when the UK market opens for business. Up around 9% in the USA at close of play yesterday and if HCM happen to release a positive Thursday RNS it could really be a great day!	lauders	Read Full Thread Reply
06/12/2018 10:00	This is probably not helping at the moment - significant price pressure in Chian on drugs, mainly generics, but the entire sector is being hit. U.S Investor sentiment against China Co's also likely to increase as the CFO of Huawei has just been arrested in Canada and the U.S request extradition. https://uk.finance.yahoo.com/news/china-apos-drugmakers-plunge-most-091532399.html	nerdofsteel	Read Full Thread Reply
05/12/2018 10:39	Good point on NASDAQ Sportii, thanks for that information	nerdofsteel	Read Full Thread Reply
05/12/2018 09:06	As long as the share price stays above 50 GBP, it shouldn’t be matter of concern. We have seen on a number of times share price bouncing back. (Not sure it would happen today, as Nasdaq closed today in respect of president Bush?) Recent announcement of multiple collaborations is indeed quite remarkable. Out of curiosity, I checked INNOVENT side of news. I found “global” term very interesting. ‘Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors’ GLA.	sportii	Read Full Thread Reply
05/12/2018 08:08	True! Yesterday was carnage in U.S markets, especially the Pharma and Biotech sectors so his chart and the golden cross technicals wouldn't have worked. It'll probably bounce today!	nerdofsteel	Read Full Thread Reply
04/12/2018 16:40	That Andreas guy on stocktwits - he's a curse. He goes short and we rally, now he's long and we drop over 5%. I think he did the same on Beigene!?	samsj	Read Full Thread Reply
04/12/2018 00:45	Thanks for the link NofS. I guess you will have more funds to use to get you nearer to your 20,000 holding now that an offer has been made for TSRO. With luck the "talent, energy, and hunger" mentioned in this piece from your link will pay-off handsomely in a few years: While Chi-Med began by building a team of returnees, it has in turn begun to train a pool of local talent. Today, 80 percent of its workers are locally educated. “[Companies] need to tap into the deep reservoir of intellect that exists here,” said CEO Hogg. “China is one of the most enterprising business environments that you’re going to come across. There’s a lot of talent, energy, and hunger.” Https://www.statnews.com/2018/12/03/pharma-valley-chinas-kendall-square/	lauders	Read Full Thread Reply
03/12/2018 17:21	Nice offer from Glaxo for my TSRO stock!	nerdofsteel	Read Full Thread Reply
03/12/2018 17:21	Nice article from today's Statnews on China's Pharma valley which includes comments from Chi-Med's CEO hxxps://www.statnews.com/2018/12/03/pharma-valley-chinas-kendall-square/	nerdofsteel	Read Full Thread Reply
03/12/2018 16:06	10:03 ET - GlaxoSmithKline falls more than 7% on the New York Stock Exchange after announcing the purchase of a cancer biotech. Glaxo says it will pay $5.1B for Tesaro, which sells a cancer drug, named Zejula, for treatment of ovarian cancer. The deal helps Glaxo gain a foothold in the lucrative cancer-drugs market. But Zejula's sales have lagged other drugs in its class, known as Parp inhibitors, notably AstraZeneca's Lynparza. And doctors and industry officials say Zejula's side-effect profile is worse than other Parps. (jonathan.rockoff@wsj.com; @jonathanrockoff)(END) Dow Jones NewswiresCan't hurt credibility,Glaxo paying up .	steeplejack	Read Full Thread Reply
03/12/2018 11:25	Well done NofS. Impressive investment/outlay so hope it all goes to plan. Good luck.	lauders	Read Full Thread Reply
03/12/2018 10:39	Just made another purchase......ultimate goal is to get back to the 20,000 holding I had 10 years ago	nerdofsteel	Read Full Thread Reply
01/12/2018 11:08	That will be the MCI tracker funds buying. It looks like lots of holders have sold into that. The buying may stop now that 30 November is passed.	nhb001	Read Full Thread Reply
01/12/2018 10:59	Lots sold but charts are very bullish at the moment with hammer candlestick	nerdofsteel	Read Full Thread Reply
30/11/2018 22:31	Question is where did all that stock come from without driving the price up more?	dbadvn	Read Full Thread Reply
30/11/2018 22:16	6.03 million ADR's traded on NASDAQ today, circa $207m worth of stock. That is unprecedented, I do not recall seeing that level of trading since the first IPO.	nerdofsteel	Read Full Thread Reply
29/11/2018 22:57	Thanks for your LSE post here too NofS. The Taizhou link worked fine at home so nice to see 3x websites working.	lauders	Read Full Thread Reply
29/11/2018 16:33	Great work Lauders and to add, here's my LSE post from this morning:- 1. Shanghai Junshi appears to be in the process of a HK IPO 2. Innovent Biologics - IPO'd in HK in early Nov 3. Taizhou Hanzhong Pharmaceuticals - private 4. Genor Biopharma - private (majority owned buy Hill House Capital)	nerdofsteel	Read Full Thread Reply
29/11/2018 11:34	Some news arrived anyway and it is all adding to the build blocks of the future. If any of these collaborations produce anything really meaningful it will just add more value to HCM than we believe at possible at present. Not too impressed that Shanghai Junshi Biosciences Co. Ltd's website doesn't seem to open for me. Found this though: Http://www.hkexnews.hk/APP/SEHK/2018/2018080501/Documents/SEHK201808060017.pdf Will take some reading! Innovent Biologics (Suzhou) Co. Ltd's website looks more promising! Http://innoventbio.com/en/#/ Will have to try the link for Taizhou Hanzhong Pharmaceuticals, Inc again at home. Doesn't want to open for me at the moment: Http://www.tianruipharm.com/ Genor Biopharma Co. Ltd's website looks more promising: Http://www.genorbio.com/en/ So two hits and two misses re: websites. Perhaps a bit like the chances of success with the collaboration efforts?	lauders	Read Full Thread Reply
29/11/2018 08:03	Cheeky timing!	mad foetus	Read Full Thread Reply

Chat Pages: 73 72 71 70 69 68 67 66 65 64 63 62 Older